AAAAAA
Results:
1-10
|
Results: 10
Authors:
BURRIS HA
RAYMOND E
AWADA A
KUHN JG
OROURKE TJ
BRENTZEL J
LYNCH W
KING SYP
BROWN TD
VONHOFF DD
Citation: Ha. Burris et al., PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Investigational new drugs, 16(1), 1998, pp. 19-27
Authors:
JOSHI AS
KING SYP
ZAJAC BA
MAKOWKA L
SHER LS
KAHAN BD
MENKIS AH
STILLER CR
SCHAEFLE B
KORNHAUSER DM
Citation: As. Joshi et al., PHASE-I SAFETY AND PHARMACOKINETIC STUDIES OF BREQUINAR SODIUM AFTER SINGLE ASCENDING ORAL DOSES IN STABLE RENAL, HEPATIC, AND CARDIAC ALLOGRAFT RECIPIENTS, Journal of clinical pharmacology, 37(12), 1997, pp. 1121-1128
Authors:
KING SYP
JOSLIN MA
RAUDIBAUGH K
PIENIASZEK HJ
BENEDEK IH
Citation: Syp. King et al., DOSE-DEPENDENT PHARMACOKINETICS OF WARFARIN IN HEALTHY-VOLUNTEERS, Pharmaceutical research, 12(12), 1995, pp. 1874-1877
Authors:
BENEDEK IH
JOSHI AS
PIENIASZEK HJ
KING SYP
KORNHAUSER DM
Citation: Ih. Benedek et al., VARIABILITY IN THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LOW-DOSE ASPIRIN IN HEALTHY MALE-VOLUNTEERS, Journal of clinical pharmacology, 35(12), 1995, pp. 1181-1186
Authors:
JOSHI AS
RAGHAVAN N
WILLIAMS RM
TAKAHASHI K
SHINGU H
KING SYP
Citation: As. Joshi et al., SIMULTANEOUS QUANTIFICATION OF AN ANTIINFLAMMATORY COMPOUND (DUP-697)AND A POTENTIAL METABOLITE (X6882) IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 660(1), 1994, pp. 143-150
Authors:
KING SYP
AGRA AM
SHEN HSL
CHI CL
ADAMS DB
CURRIE VE
BERTINO JR
PIENIASZEK HJ
QUON CY
Citation: Syp. King et al., PROTEIN-BINDING OF BREQUINAR IN THE PLASMA OF HEALTHY DONORS AND CANCER-PATIENTS AND ANALYSIS OF THE RELATIONSHIP BETWEEN PROTEIN-BINDING AND PHARMACOKINETICS IN CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 101-108
Authors:
JOSHI AS
PIENIASZEK HJ
QUON CY
KING SYP
Citation: As. Joshi et al., PLASMA-PROTEIN BINDING OF HIGHLY BOUND DRUGS - IMPLICATIONS OF RADIOCHEMICAL IMPURITIES, Journal of pharmaceutical sciences, 83(8), 1994, pp. 1187-1188
Authors:
SHER LS
EIRASHREHA G
KORNHAUSER DM
KING SYP
PODESTA LG
HOFFMAN AL
MEEHAN M
JOSHI AS
NOGUCHI H
PAN SH
CRAMER D
MAKOWKA L
Citation: Ls. Sher et al., SAFETY AND PHARMACOKINETICS (PK) OF BREQUINAR SODIUM (BQR) IN LIVER ALLOGRAFT RECIPIENTS ON CYCLOSPORINE (CYA) AND STEROIDS, Hepatology, 18(3), 1993, pp. 746-746
Authors:
GRAY JE
PETERMAN V
NEWTON R
KING SYP
PIENIASZEK HJ
Citation: Je. Gray et al., ELISA DETERMINATION AND PRELIMINARY PHARMACOKINETICS OF MODIFIED HUMAN RIL-1 BETA IN DOGS, Research communications in chemical pathology and pharmacology, 81(2), 1993, pp. 233-241
Authors:
KING SYP
POWEL RJ
WONG YN
DAVIDSON AF
VINCENT DR
QUON CY
PIENIASZEK HJ
Citation: Syp. King et al., EFFECTS OF MULTIPLE DOSES OF MORICIZINE HYDROCHLORIDE ON ITS PHARMACOKINETICS AND HEPATIC-MICROSOMAL ENZYMES IN RATS, Research communications in chemical pathology and pharmacology, 75(3), 1992, pp. 259-274
Risultati:
1-10
|